Twentyfirst Century Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 11-01-2025
- Paid Up Capital ₹ 1.52 Cr
as on 11-01-2025
- Company Age 38 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 37.76 Cr
as on 11-01-2025
- Satisfied Charges ₹ 9.23 Cr
as on 11-01-2025
- Revenue 31.88%
(FY 2022)
- Profit 123.02%
(FY 2022)
- Ebitda 513.59%
(FY 2022)
- Net Worth 3.10%
(FY 2022)
- Total Assets 6.79%
(FY 2022)
About Twentyfirst Century Pharmaceuticals
The Corporate was formerly known as 21St Century Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.52 Cr.
The company currently has active open charges totaling ₹37.76 Cr. The company has closed loans amounting to ₹9.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vengandur Raghunathan, Krishnaswamy Saroja, and Vengandur Vijayaraghavan serve as directors at the Company.
- CIN/LLPIN
U24231TN1986PTC012817
- Company No.
012817
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 1986
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Twentyfirst Century Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vengandur Raghunathan  | Managing Director | 21-Mar-1986 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vengandur Vijayaraghavan | Director | 22-Feb-2019 | Current |
| Krishnaswamy Saroja | Director | 30-Sep-2004 | Current |
Financial Performance of Twentyfirst Century Pharmaceuticals.
Twentyfirst Century Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.88% increase. The company also saw a substantial improvement in profitability, with a 123.02% increase in profit. The company's net worth moved up by a moderate rise of 3.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Twentyfirst Century Pharmaceuticals?
In 2022, Twentyfirst Century Pharmaceuticals had a promoter holding of 92.89% and a public holding of 7.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avicence Research Private LimitedActive 5 years 30 daysVengandur Raghunathan and Krishnaswamy Saroja are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Dec 2021 | ₹2.75 Cr | Open |
Canara Bank Creation Date: 25 Oct 2019 | ₹2.00 Cr | Open |
Canara Bank Creation Date: 21 Oct 2009 | ₹33.00 Cr | Open |
How Many Employees Work at Twentyfirst Century Pharmaceuticals?
Twentyfirst Century Pharmaceuticals has a workforce of 46 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Twentyfirst Century Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Twentyfirst Century Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
